Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimebutine and Probiotics for FAPD in Children
NCT06268964Phase 2Recruiting
- Sponsor
- Universidad de Colima
- Start
- Sep 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of trimebutine, lactobacillus rhamnosus, sponsored by Universidad de Colima. Started Sep 2024; status: recruiting.
02
Drugs
trimebutinelactobacillus rhamnosus
Beyond the preview
Go deeper on NCT06268964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06268964.